nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—ADRA1B—polycystic ovary syndrome	0.472	0.598	CbGaD
Acepromazine—ADRA1A—polycystic ovary syndrome	0.318	0.402	CbGaD
Acepromazine—SLC22A1—Metformin—polycystic ovary syndrome	0.0945	1	CbGbCtD
Acepromazine—Propericiazine—ADRA1B—polycystic ovary syndrome	0.000569	0.104	CrCbGaD
Acepromazine—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.000357	0.0653	CrCbGaD
Acepromazine—Propiomazine—ADRA1D—polycystic ovary syndrome	0.000342	0.0626	CrCbGaD
Acepromazine—Methotrimeprazine—ADRA1D—polycystic ovary syndrome	0.000293	0.0536	CrCbGaD
Acepromazine—Propiomazine—ADRA1B—polycystic ovary syndrome	0.000292	0.0534	CrCbGaD
Acepromazine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.000262	0.0479	CrCbGaD
Acepromazine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.000256	0.0468	CrCbGaD
Acepromazine—Promazine—ADRA1D—polycystic ovary syndrome	0.000254	0.0464	CrCbGaD
Acepromazine—Methotrimeprazine—ADRA1B—polycystic ovary syndrome	0.00025	0.0457	CrCbGaD
Acepromazine—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.00024	0.044	CrCbGaD
Acepromazine—Imipramine—ADRA1D—polycystic ovary syndrome	0.000222	0.0406	CrCbGaD
Acepromazine—Promazine—ADRA1B—polycystic ovary syndrome	0.000216	0.0396	CrCbGaD
Acepromazine—Propiomazine—ADRA1A—polycystic ovary syndrome	0.000197	0.036	CrCbGaD
Acepromazine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.00019	0.0349	CrCbGaD
Acepromazine—Imipramine—ADRA1B—polycystic ovary syndrome	0.000189	0.0347	CrCbGaD
Acepromazine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.000176	0.0322	CrCbGaD
Acepromazine—Trimipramine—ADRA1A—polycystic ovary syndrome	0.000172	0.0315	CrCbGaD
Acepromazine—Methotrimeprazine—ADRA1A—polycystic ovary syndrome	0.000168	0.0308	CrCbGaD
Acepromazine—Promethazine—ADRA1A—polycystic ovary syndrome	0.000166	0.0303	CrCbGaD
Acepromazine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.000163	0.0299	CrCbGaD
Acepromazine—Promazine—ADRA1A—polycystic ovary syndrome	0.000146	0.0267	CrCbGaD
Acepromazine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.000128	0.0235	CrCbGaD
Acepromazine—Imipramine—ADRA1A—polycystic ovary syndrome	0.000128	0.0233	CrCbGaD
Acepromazine—Desipramine—ADRB2—polycystic ovary syndrome	8.94e-05	0.0164	CrCbGaD
Acepromazine—DRD1—Signaling Pathways—PGR—polycystic ovary syndrome	1.75e-05	0.000159	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	1.74e-05	0.000159	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.73e-05	0.000158	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.73e-05	0.000158	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.73e-05	0.000157	CbGpPWpGaD
Acepromazine—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	1.72e-05	0.000157	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.72e-05	0.000157	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.72e-05	0.000157	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	1.71e-05	0.000156	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.71e-05	0.000156	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.69e-05	0.000154	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.69e-05	0.000154	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.68e-05	0.000154	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	1.68e-05	0.000153	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.66e-05	0.000151	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.66e-05	0.000151	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	1.64e-05	0.000149	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.64e-05	0.000149	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	1.63e-05	0.000149	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.63e-05	0.000148	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.63e-05	0.000148	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.62e-05	0.000148	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	1.62e-05	0.000148	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	1.62e-05	0.000147	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.61e-05	0.000147	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	1.61e-05	0.000147	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.61e-05	0.000146	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.6e-05	0.000146	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.59e-05	0.000145	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.59e-05	0.000145	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.59e-05	0.000145	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.57e-05	0.000143	CbGpPWpGaD
Acepromazine—ALB—Metabolism—LHB—polycystic ovary syndrome	1.57e-05	0.000143	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.57e-05	0.000143	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.57e-05	0.000143	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.56e-05	0.000142	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.55e-05	0.000142	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.55e-05	0.000141	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	1.55e-05	0.000141	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.54e-05	0.000141	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.54e-05	0.00014	CbGpPWpGaD
Acepromazine—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	1.54e-05	0.00014	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.52e-05	0.000138	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.51e-05	0.000138	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	1.51e-05	0.000138	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.51e-05	0.000137	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.5e-05	0.000137	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	1.49e-05	0.000136	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.49e-05	0.000136	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	1.49e-05	0.000135	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.47e-05	0.000134	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.47e-05	0.000134	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—TH—polycystic ovary syndrome	1.46e-05	0.000133	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.46e-05	0.000133	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.45e-05	0.000132	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.44e-05	0.000131	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	1.43e-05	0.00013	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.43e-05	0.00013	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	1.43e-05	0.00013	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.42e-05	0.00013	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PRL—polycystic ovary syndrome	1.42e-05	0.000129	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.42e-05	0.000129	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	1.4e-05	0.000128	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.4e-05	0.000127	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.4e-05	0.000127	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.37e-05	0.000125	CbGpPWpGaD
Acepromazine—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	1.37e-05	0.000125	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.37e-05	0.000125	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.35e-05	0.000123	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.35e-05	0.000123	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.35e-05	0.000123	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.33e-05	0.000122	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.33e-05	0.000122	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Acepromazine—ALB—Metabolism—RRM2—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	1.32e-05	0.00012	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.31e-05	0.00012	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.31e-05	0.000119	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.3e-05	0.000119	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	1.3e-05	0.000118	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.29e-05	0.000118	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.28e-05	0.000117	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.28e-05	0.000117	CbGpPWpGaD
Acepromazine—ALB—Metabolism—YAP1—polycystic ovary syndrome	1.28e-05	0.000116	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.27e-05	0.000116	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—IGF1—polycystic ovary syndrome	1.27e-05	0.000116	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—AKT2—polycystic ovary syndrome	1.27e-05	0.000116	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.27e-05	0.000116	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.25e-05	0.000114	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.24e-05	0.000113	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Acepromazine—ALB—Metabolism—NAMPT—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.22e-05	0.000111	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.22e-05	0.000111	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.22e-05	0.000111	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	1.21e-05	0.00011	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.21e-05	0.00011	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.21e-05	0.00011	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	1.21e-05	0.00011	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.2e-05	0.00011	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	1.19e-05	0.000108	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.19e-05	0.000108	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.18e-05	0.000108	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.18e-05	0.000108	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.18e-05	0.000108	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.18e-05	0.000107	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.17e-05	0.000107	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	1.17e-05	0.000107	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.17e-05	0.000106	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.16e-05	0.000106	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.16e-05	0.000106	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.16e-05	0.000106	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.16e-05	0.000105	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.15e-05	0.000105	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	1.14e-05	0.000104	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.14e-05	0.000104	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.14e-05	0.000104	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.14e-05	0.000104	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	1.13e-05	0.000103	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.13e-05	0.000103	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	1.13e-05	0.000103	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.12e-05	0.000102	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.12e-05	0.000102	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.12e-05	0.000102	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.1e-05	0.0001	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.1e-05	0.0001	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.1e-05	9.98e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	1.08e-05	9.85e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.07e-05	9.79e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	1.07e-05	9.78e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.07e-05	9.78e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	1.07e-05	9.76e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.06e-05	9.69e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.06e-05	9.63e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	1.05e-05	9.6e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.04e-05	9.49e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.03e-05	9.43e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.03e-05	9.41e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.03e-05	9.4e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.02e-05	9.31e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.02e-05	9.31e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.02e-05	9.26e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.02e-05	9.25e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1e-05	9.14e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	1e-05	9.13e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1e-05	9.11e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	9.99e-06	9.11e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.94e-06	9.06e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.79e-06	8.92e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—LEP—polycystic ovary syndrome	9.78e-06	8.91e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—TH—polycystic ovary syndrome	9.75e-06	8.88e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.73e-06	8.87e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	9.56e-06	8.71e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	9.49e-06	8.64e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	9.42e-06	8.58e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	9.27e-06	8.45e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	9.08e-06	8.27e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.97e-06	8.18e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	8.92e-06	8.13e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.83e-06	8.05e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	8.81e-06	8.03e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	8.72e-06	7.95e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	8.67e-06	7.9e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.65e-06	7.88e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.59e-06	7.83e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	8.49e-06	7.73e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	8.41e-06	7.66e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	8.4e-06	7.66e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	8.36e-06	7.61e-05	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	8.31e-06	7.57e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	8.18e-06	7.46e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	8.12e-06	7.4e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.08e-06	7.36e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.08e-06	7.36e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	8.01e-06	7.3e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	8.01e-06	7.3e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	7.97e-06	7.26e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GNAS—polycystic ovary syndrome	7.96e-06	7.25e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.67e-06	6.99e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—NCOR1—polycystic ovary syndrome	7.58e-06	6.91e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	7.55e-06	6.88e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.5e-06	6.84e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	7.42e-06	6.77e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	7.38e-06	6.73e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	7.27e-06	6.62e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	7.27e-06	6.62e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	7.22e-06	6.58e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	7.19e-06	6.55e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	7.18e-06	6.55e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	7.15e-06	6.51e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	7.11e-06	6.48e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.95e-06	6.33e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.94e-06	6.33e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	6.88e-06	6.27e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	6.84e-06	6.23e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—MTHFR—polycystic ovary syndrome	6.7e-06	6.11e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.62e-06	6.03e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.61e-06	6.03e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.6e-06	6.01e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	6.59e-06	6e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.48e-06	5.91e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.35e-06	5.78e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	6.34e-06	5.78e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	6.31e-06	5.75e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.28e-06	5.73e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	6.24e-06	5.69e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	6.21e-06	5.66e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.18e-06	5.63e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	6.11e-06	5.57e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.1e-06	5.56e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.1e-06	5.56e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	6.08e-06	5.54e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	6e-06	5.47e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	6e-06	5.47e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.88e-06	5.36e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.87e-06	5.35e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.79e-06	5.28e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.7e-06	5.2e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.58e-06	5.09e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PPARG—polycystic ovary syndrome	5.43e-06	4.95e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—POMC—polycystic ovary syndrome	5.36e-06	4.88e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—INS—polycystic ovary syndrome	5.33e-06	4.86e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.31e-06	4.84e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.28e-06	4.81e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	5.06e-06	4.61e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.67e-06	4.25e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.59e-06	4.18e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.54e-06	4.14e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.5e-06	4.1e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.32e-06	3.94e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.99e-06	3.63e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.92e-06	3.57e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.84e-06	3.5e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	3.65e-06	3.33e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.14e-06	2.86e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	2.99e-06	2.72e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	2.76e-06	2.51e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.71e-06	2.47e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.66e-06	2.42e-05	CbGpPWpGaD
